We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
-2.92%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$1.93B
AUM Growth
-$130M
Cap. Flow
-$54.2M
Cap. Flow %
-2.81%
Top 10 Hldgs %
30.03%
Holding
2,489
New
31
Increased
1,105
Reduced
525
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Healthcare 11.48%
3 Financials 10.72%
4 Consumer Discretionary 9.28%
5 Industrials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMP icon
1501
Tompkins Financial
TMP
$1.44B
$42.5K ﹤0.01%
867
+121
+16% +$6.56K
VERV
1502
DELISTED
Verve Therapeutics
VERV
$42.4K ﹤0.01%
3,201
+403
+14% +$6.49K
IE icon
1503
Ivanhoe Electric
IE
$1.7B
$42.2K ﹤0.01%
3,544
+452
+15% +$6.79K
FLNA
1504
Filana Therapeutics
FLNA
$45.7M
$42.1K ﹤0.01%
2,530
+377
+18% +$7.47K
CMRC
1505
Commerce.com Inc Series 1
CMRC
$179M
$42.1K ﹤0.01%
4,261
+640
+18% +$6.67K
ACCD
1506
DELISTED
Accolade Inc
ACCD
$41.9K ﹤0.01%
3,959
+301
+8% +$3.95K
BKD icon
1507
Brookdale Senior Living
BKD
$3B
$41.9K ﹤0.01%
10,115
PTLO icon
1508
Portillo's
PTLO
$365M
$41.9K ﹤0.01%
2,721
+370
+16% +$7.23K
PRLB icon
1509
Protolabs
PRLB
$2.17B
$41.9K ﹤0.01%
1,586
+191
+14% +$5.77K
KE
1510
Kimball Electronics
KE
$606M
$41.8K ﹤0.01%
1,528
+245
+19% +$7.01K
RES icon
1511
RPC Inc
RES
$1.4B
$41.7K ﹤0.01%
4,661
RDUS
1512
DELISTED
Radius Recycling
RDUS
$41.6K ﹤0.01%
1,494
+125
+9% +$3.87K
UTL icon
1513
Unitil
UTL
$992M
$41.6K ﹤0.01%
973
+136
+16% +$6.66K
CTKB icon
1514
Cytek Biosciences
CTKB
$636M
$41.3K ﹤0.01%
7,489
+793
+12% +$6.36K
VRDN icon
1515
Viridian Therapeutics
VRDN
$2.49B
$41.2K ﹤0.01%
2,685
+377
+16% +$7.19K
BBBY
1516
Bed Bath & Beyond
BBBY
$423M
$41.1K ﹤0.01%
2,861
+144
+5% +$3.52K
SBOW
1517
DELISTED
SilverBow Resources, Inc.
SBOW
$41.1K ﹤0.01%
1,148
+179
+18% +$6.53K
NRC icon
1518
NRC Health Common Stock
NRC
$471M
$41K ﹤0.01%
923
+162
+21% +$7.07K
TRNS icon
1519
Transcat
TRNS
$888M
$40.9K ﹤0.01%
417
HZO icon
1520
MarineMax
HZO
$1.15B
$40.7K ﹤0.01%
1,240
RYZ
1521
Ryerson Holding Corp
RYZ
$1.5B
$40.7K ﹤0.01%
1,399
+166
+13% +$5.63K
VISN
1522
Vistance Networks Inc
VISN
$2.62B
$40.5K ﹤0.01%
12,060
+980
+9% +$4.01K
NSSC icon
1523
Napco Security Technologies
NSSC
$1.39B
$40.5K ﹤0.01%
1,818
+120
+7% +$3.64K
DCOM icon
1524
Dime Commercial Bancshares
DCOM
$1.81B
$40.3K ﹤0.01%
2,021
+164
+9% +$3.42K
BXC icon
1525
BlueLinx
BXC
$701M
$40.2K ﹤0.01%
490
+38
+8% +$3.34K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2023 Portfolio in Review

As of Q3 2023, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $1.93B, down 6.3% from $2.06B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.9%. Metropolitan Life Insurance Company (MetLife) opened 31 new positions and exited 91, leaving the 2,489-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2023 buy was Vanguard Long-Term Corporate Bond ETF: 296,480 shares worth $21.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q3 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $10.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited State Street SPDR Portfolio Long Term Corporate Bond ETF in Q3 2023, selling an estimated $23.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 30% of its $1.93B portfolio in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 31 new positions and closed 91 in Q3 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 6.3% quarter-over-quarter to $1.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.